[{"author":"GlaucusResearch","content":"Glaucus Issues a Comprehensive Rebuttal to Blue Sky $BLA #ASX  https:\/\/t.co\/Irym6qUXXd","pubdate":"20180405015355","NumFavorite":17,"NumShare":5,"CrawlerDate":20200720},{"author":"GlaucusResearch","content":"$BLA Blue Sky\u2019s response is woefully inadequate.  Rather than address our Report on its merits, Blue Sky has double\u2026 https:\/\/t.co\/ZgUNQAOGhd","pubdate":"20180405015546","NumFavorite":9,"NumShare":4,"CrawlerDate":20200720},{"author":"GlaucusResearch","content":"Only after Glaucus exposed Blue Sky for overstating its fee earning AUM (as calculated in the same way as other alt\u2026 https:\/\/t.co\/V2xKzYTjiF","pubdate":"20180405015837","NumFavorite":10,"NumShare":2,"CrawlerDate":20200720},{"author":"GlaucusResearch","content":"We call on $BLA Blue Sky to provide the same level of transparency as the asset managers to which it compares itsel\u2026 https:\/\/t.co\/SinNMgT1Sf","pubdate":"20180405020143","NumFavorite":12,"NumShare":1,"CrawlerDate":20200720},{"author":"CitronResearch","content":"Citron pressing $NVDA short expect sub $200 soon.  Mkt starting to realize that ML\/DL is narrowing and hyper-scale\u2026 https:\/\/t.co\/o0tadSZKXC","pubdate":"20180405170844","NumFavorite":142,"NumShare":81,"CrawlerDate":20200720}]